AMARIN CORP PLC\UK (AMRN)

↓ Download CSV

CIK 0000897448 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated X0
  • Fiscal year ends Dec 31

In fiscal 2025, AMARIN CORP PLC\UK reported revenue of $213.65M, down 6.5% from the prior year. The company ran a net loss, with a net margin of -18.2% and a gross margin of 56.6%. It held $670.77M in total assets against $211.49M in total liabilities.

Key ratios (FY2025)

56.6%
Gross margin
-23.5%
Operating margin
-18.2%
Net margin
-8.4%
Return on equity
-6.5%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$213.65M$228.61M$306.91M$369.19M$583.19M$614.06M$429.75M$229.21M$181.10M$130.08M
Cost of Revenue$121.33M$131.44M$96.02M$54.54M$44.95M$34.36M
Gross Profit$120.87M$81.38M$165.54M$242.48M$461.86M$482.62M$333.74M$174.67M$136.15M$95.72M
Operating Income-$50.17M-$91.80M-$67.59M-$105.87M$10.50M-$19.66M-$24.28M-$108.22M-$45.55M-$65.63M
Net Income-$38.80M-$82.18M-$59.11M-$105.80M$7.73M-$18.00M-$22.64M-$116.44M-$67.86M-$86.35M
EPS (Diluted)$-0.09$-0.20$-0.15$-0.26$0.02$-0.05$-0.07$-0.39$-0.25$-0.41
Total Assets$670.77M$685.35M$831.68M$886.18M$1.07B$966.02M$882.21M$385.71M$161.60M$167.00M
Total Liabilities$211.49M$199.17M$279.59M$290.85M$400.97M$338.52M$273.95M$233.38M$226.70M$176.06M
Shareholders' Equity$459.28M$486.18M$552.10M$595.33M$667.10M$627.50M$608.26M$152.33M-$65.10M-$9.06M
Cash & Equivalents$134.66M$121.04M$199.25M$217.67M$219.45M$186.96M$644.59M$249.23M$73.64M$98.25M
Operating Cash Flow$6.73M-$31.02M$6.88M-$180.09M-$66.54M-$21.75M-$9.37M-$94.70M-$32.84M-$71.81M
Capital Expenditures$252.0K$2.48M$58.0K$12.0K$21.0K
Shares Outstanding416.21M411.58M408.82M408.82M396.60M392.54M360.10M325.85M271.02M269.36M